The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has led to an unprecedented effort toward the development of an effective …

Over the past decades, considerable attention has been dedicated to the exploitation of
diverse immune cells as therapeutic and/or diagnostic cell‐based microrobots for hard‐to …

Adoptive T cell therapy has successfully been implemented for the treatment of cancer.
Nevertheless, ex vivo expansion of T cells by artificial antigen-presenting cells (aAPCs) …

Non-pharmacological interventions and tracing-testing strategy proved insufficient to reduce
SARS-CoV-2 spreading worldwide. Several vaccines with different mechanisms of action …

Mutation-derived neoantigens are taking central stage as a determinant in eliciting effective
antitumor immune responses following adoptive T-cell therapies. These mutations are …

At present, effective vaccines have been developed as the most successful approaches for
preventing widespread infectious disease. The global efforts are focusing with the aim of …

Diffusing alpha-emitting radiation therapy (DaRT) employs intratumoral Ra-224-coated
seeds that efficiently destroy solid tumors by slowly releasing alpha-emitting atoms inside …

Tools for genome-wide rapid identification of peptide–major histocompatibility complex
targets of T-cell receptors (TCR) are not yet universally available. We present a new antigen …

Antigenic peptides play a central role in immune surveillance in cancer, infectious disease,
autoimmunity, and allergy. The identification and isolation of antigenic peptides for T cell …

Antigen-specificity of T cells provides important clues to the pathogenesis of T cell-mediated
autoimmune diseases and immune-evasion strategies of tumors. Identification of T cell …